InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Booth Bruce, Chairman & CEO. Director active across 3 companies, notably Kymera Therapeutics, Inc.. Cumulatively, 4 reports have been recorded. Total volume traded: €25.2m. The latest transaction was filed on 11 August 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
2,831,520 sharesCommon StockSEC:0000899243-22-001651
2,831,520 sharesCommon StockSEC:0000899243-22-001651:0
242,133 shares@ €51.95070.20% mcap100.0% of flowCommon StockSEC:0001209191-21-051016
242,133 shares@ €51.95070.20% mcap100.0% of flowCommon StockSEC:0001209191-21-051016:0
4 of 4 declarations
About Booth Bruce
Daniel J. Starck is the Chief Executive Officer and Executive Vice President, President Patient Direct at Apria, Inc. and Owens & Minor Inc. In these roles, he oversees the operations and strategy of the company, focusing on improving patient care. Daniel is responsible for the strategic direction and growth of both companies, playing a key role in innovation and operational efficiency.
